Santen Pharmaceutical Co Stock Performance
as on November 20, 2026 at 6:29 am IST
Day's High
$12.56$12.711.19%
Upside

52 Week's Low
52 Week's High

100.00%
Downside
-100.00%
Upside

Santen Pharmaceutical Co share price movements today
- Previous Close
- $12.59
- Open
- $12.71
- Volume
- 78.8K
- Market Cap
- $4.1B
- Dividend Yield
- 1.76%
- Day's Low - High
- $12.56 - $12.71
Santen Pharmaceutical Co Historical Returns
- 1 Month Return
- + 10.56 %
- 3 Month Return
- + 1.32 %
- 1 Year Return
- + 25.04 %
- 3 Year Return
- + 41.12 %
- 5 Year Return
- 0 %
Santen Pharmaceutical Co Stock Fundamentals & Key Indicators
Check Santen Pharmaceutical Co market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$4.1B
EPS (TTM)
122.67
Dividend Yield
1.76%
PE Ratio (TTM)
17.1
Industry PE ratio
4.56
PEG Ratio
0.58
Return On Equity TTM
13.12%
Santen Pharmaceutical Co vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Santen Pharmaceutical Co with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| NA | $4.1B | NA | 17.10 | 56.15% | 1.76% | |
| StrongBuy | $1.3T | 418.27% | 44.76 | 83.63% | 0.50% | |
| StrongBuy | $505.6B | 143.93% | 49.05 | 73.72% | 2.42% | |
| Buy | $670.9B | 64.00% | 41.34 | 67.56% | 1.94% | |
| StrongBuy | $286.8B | 60.70% | 25.61 | 77.59% | 1.76% |
Stock Returns calculator for Santen Pharmaceutical Co Stock including INR - Dollar returns
The Santen Pharmaceutical Co stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Santen Pharmaceutical Co investment value today
Current value as on today
₹1,31,818
Returns
₹31,818
(+31.82%)
Returns from Santen Pharmaceutical Co Stock
₹25,037 (+25.04%)
Dollar Impact
₹6,780 (+6.78%)
Indian Investors' Interest in Santen Pharmaceutical Co Stock
Search interest for Santen Pharmaceutical Co Stock has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Santen Pharmaceutical Co Quarterly Profit & Loss
All numbers in Millions USD
Santen Pharmaceutical Co Annual Profit & Loss
All numbers in Millions USD
Santen Pharmaceutical Co Quarterly Cash Flow
All numbers in Millions USD
Santen Pharmaceutical Co Annual Cash Flow
All numbers in Millions USD
Insights on Santen Pharmaceutical Co
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years

In the last 3 years, SNPHY has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACTPrice Rise

In the last 1 month, SNPHY stock has moved up by 10.6%
POSITIVE IMPACTRevenue Rich

Revenue is up for the last 2 quarters, 69.86B → 74.33B (in $), with an average increase of 6.0% per quarter
POSITIVE IMPACTProfit Spike

Netprofit is up for the last 2 quarters, 7.28B → 8.25B (in $), with an average increase of 11.7% per quarter
NO EFFECTAgainst Peers

In the last 1 year, Merck & Co., Inc. has given 39.8% return, outperforming this stock by 14.8%
About Santen Pharmaceutical Co
| Organisation | Santen Pharmaceutical Co |
| Headquarters | Grand Front Osaka Tower A, Kita, OS, 530-8552, JP |
| Industry | Drug Manufacturers - General |
| CEO | Takeshi Ito |
Key Management of Santen Pharmaceutical Co
Name | Title |
|---|---|
Mr. Daisuke Nakata | Chief Digital & Information Officer |
Ms. Kaori Itagaki | General Manager of Investor Relations Group |
Ms. Mika Masunari | Corporate Officer, General Counsel, Chief Risk Officer & Chief Compliance Officer |
Mr. Shinichi Teramachi | Corp. Officer, Head of Sales and Head of Japan Sales & Marketing |
Ms. Yoko Saiki | Corporate Officer & Chief Human Resources Officer |
Mr. Takeshi Ito | President, CEO & Representative Director |
Ms. Rie Nakajima | COO & Director |
Mr. Kazuo Koshiji | CFO & Corporate Officer |
Ms. Marianthi Psacha | Corporate Officer, Head of EMEA Business and International Pricing Market Access & Public Affairs |
Mr. Kenji Morishima | Corporate Officer & Head of China Product Development Department |
FAQs
What is Santen Pharmaceutical Co share price today?
Santen Pharmaceutical Co share price today is $12.56 as on at the close of the market. Santen Pharmaceutical Co share today touched a day high of $12.71 and a low of $12.56.
What is the 52 week high and 52 week low for Santen Pharmaceutical Co share?
Santen Pharmaceutical Co share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Santen Pharmaceutical Co stock price today i.e. is closed at $12.56,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.
What is Santen Pharmaceutical Co's market capitalisation today?
Santen Pharmaceutical Co market capitalisation is $0.00T as on .
How to invest in Santen Pharmaceutical Co Stock (SNPHY) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Santen Pharmaceutical Co on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Santen Pharmaceutical Co Stock (SNPHY) from India?
Indian investors can start investing in Santen Pharmaceutical Co (SNPHY) shares with as little as ₹93.29000091552734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹932.90 in Santen Pharmaceutical Co stock (as per the Rupee-Dollar exchange rate as on ).
Based on Santen Pharmaceutical Co share’s latest price of $12.56 as on November 20, 2026 at 12:59 am IST, you will get 0.7962 shares of Santen Pharmaceutical Co. Learn more about
fractional shares .